{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "NANOVIRICIDES NEW  DL-,01", "longName": "NanoViricides, Inc.", "messageBoardId": "finmb_22594191", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.1, "averageDailyVolume3Month": 16, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.09899998, "fiftyTwoWeekLowChangePercent": 0.097922824, "fiftyTwoWeekRange": "1.011 - 3.669", "fiftyTwoWeekHighChange": -2.559, "fiftyTwoWeekHighChangePercent": -0.69746524, "fiftyTwoWeekLow": 1.011, "fiftyTwoWeekHigh": 3.669, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.55, "sharesOutstanding": 11635000, "bookValue": 1.708, "fiftyDayAverage": 1.17879, "fiftyDayAverageChange": -0.06878996, "fiftyDayAverageChangePercent": -0.058356415, "twoHundredDayAverage": 1.544975, "twoHundredDayAverageChange": -0.43497503, "twoHundredDayAverageChangePercent": -0.2815418, "marketCap": 12914850, "priceToBook": 0.6498829, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 0.90909004, "regularMarketPrice": 1.11, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1473314400000, "priceHint": 4, "regularMarketChange": 0.00999999, "regularMarketTime": 1683892036, "regularMarketDayHigh": 1.11, "regularMarketDayRange": "1.1 - 1.11", "regularMarketDayLow": 1.1, "regularMarketVolume": 1000, "regularMarketPreviousClose": 1.1, "bid": 1.09, "ask": 1.15, "symbol": "NV3P.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 Controls Drive", "city": "Shelton", "state": "CT", "zip": "06484", "country": "United States", "phone": "203 937 6137", "fax": "203 859 5095", "website": "https://www.nanoviricides.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anil R. Diwan Ph.D.", "age": 63, "title": "Exec. Chairman, Pres, CEO & Sec.", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 400000, "fmt": "400k", "longFmt": "400,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA", "age": 63, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 129600, "fmt": "129.6k", "longFmt": "129,600"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Randall W. Barton Ph.D.", "age": 75, "title": "Chief Scientific Officer & Chief Regulatory Officer", "yearBorn": 1947, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}